PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $49,000 | +145.0% | 5,315 | +231.4% | 0.00% | -60.0% |
Q2 2019 | $20,000 | +900.0% | 1,604 | +4235.1% | 0.01% | +400.0% |
Q2 2018 | $2,000 | -33.3% | 37 | -24.5% | 0.00% | -50.0% |
Q1 2018 | $3,000 | -25.0% | 49 | +22.5% | 0.00% | -33.3% |
Q4 2017 | $4,000 | 0.0% | 40 | -66.4% | 0.00% | -25.0% |
Q4 2016 | $4,000 | -84.6% | 119 | -86.8% | 0.00% | -92.2% |
Q1 2016 | $26,000 | – | 900 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
Eversept Partners, LP | 58,251 | $491,638 | 0.12% |